IL11 and carcinoma: In the secondary approach, which evaluated all 1,505 CpG loci at <0.1% FDR, THBS2_P605_R, ERG_E28_F, EYA4_E277_F, and NPY_P295_F probes were differentially methylated across all three carcinoma types, THBS2_P605_R and PTGS2_P524_R were differentially methylated between endometrioid and clear cell types, IL11_E232_F was differentially methylated between serous and endometrioid types, and IGF2AS_P203_F and ERG_E28_F were differentially methylated between serous and clear cell types (data not shown).